Trial intelligence / Profile preview

Preventive correction of fibrinolysis with epsilon aminocaproic acid during liver transplantation

RBR-105p888fCompleted

Sponsor
José Carlos Rodrigues Nascimento
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in hyperfibrinolysis comparing Epsilon aminocaproic acid with Placebo saline (2 arms). Started May 2014; status: completed.

02

Drugs

aminocaproic acid
03

Conditions

hyperfibrinolysis

Beyond the preview

Go deeper on RBR-105p888f.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-105p888f.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call